MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517042217 A) filed by Tubulis Gmbh, Planegg, Germany, on May 1, for 'novel anti-napi2b antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof.'
Inventor(s) include Helma-Smets, Jonas; Vogl, Annette; Mai, Isabelle; Herterich, Sarah; Schumacher, Dominik; Kasper, Marc-Andr; Cyprys, Philipp; Gerlach, Marcus; and Schmitt, Saskia.
The application for the patent was published on Aug. 8, under issue no. 32/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel anti-NaPi2b antibodies, antibody-drug-conjugates (ADCs) based thereon as well as to therapeutic met...